Listed

Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Reports and events: 561 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
FiledFormWhat it isAccession number
2011-04-0513:15 ET6-KReport of a foreign private issuerPeriod 2011-04-040001193125-11-088752
2011-03-3113:16 ET6-KReport of a foreign private issuerPeriod 2011-03-300001193125-11-084022
2011-03-3013:16 ET6-KReport of a foreign private issuerPeriod 2011-03-300001193125-11-082188
2011-03-1714:18 ET6-KReport of a foreign private issuerPeriod 2011-03-170001193125-11-069572
2011-01-1022:27 ET6-KReport of a foreign private issuerPeriod 2011-01-100001193125-11-005239
2010-12-2217:29 ET6-KReport of a foreign private issuerPeriod 2010-12-220001193125-10-286327
2010-11-2221:43 ET6-KReport of a foreign private issuerPeriod 2010-11-220001193125-10-266437
2010-11-1719:21 ET6-KReport of a foreign private issuerPeriod 2010-11-170001193125-10-262880
2010-11-1601:30 ET6-KReport of a foreign private issuerPeriod 2010-11-150001193125-10-261134
2010-11-1521:05 ET6-KReport of a foreign private issuerPeriod 2010-11-150001193125-10-260623
2010-11-1220:32 ET6-KReport of a foreign private issuerPeriod 2010-11-120001193125-10-258726

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.